Comparing ways to deliver radiation therapy to liver tumors
Part of Cancer clinical trials.
This study compares two ways of delivering radiation therapy (Y-90) directly to liver tumors. It aims to see if a special catheter that blocks blood flow (balloon catheter) can deliver the radiation more effectively and safely than the standard method.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have multiple liver tumors that have spread from another part of your body.
- Your doctor has already decided that radioembolization (Y-90) is a good treatment option for you.
- You are 18 years or older.
- You are generally able to take care of yourself (up and about at least half of the day).
- You are willing to give written consent to participate.
- You have at least two areas in the liver that can be treated with the study device, and each area has at least one measurable tumor.
- Your liver blood vessels are suitable for the study's special catheter.
- You are not pregnant or breastfeeding.
- You have not had a previous blockage procedure (embolization) in the liver area to be treated.
- The expected radiation dose to your lungs is within safe limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special catheter (TriNav) to deliver radiation directly to liver tumors. It aims to improve targeting and reduce side effects for people with liver cancer that cannot be surgically removed.
This study tests whether a targeted radiation treatment called Y-90 segmentectomy can shrink liver tumors. It is for people with one to three small liver tumors that cannot be removed by surgery or destroyed by heat or cold (ablation).
This study tests a targeted radiation treatment called Y90 for liver tumors that are too large for standard approaches. It aims to see how well the treatment works for people with primary or secondary liver cancers that mainly affect the liver and have at least one tumor bigger than 5 cm.
This trial tests a treatment called yttrium-90 carbon microsphere radioembolization for people with liver cancer that has been previously treated. Tiny radioactive beads are delivered directly to the tumor through the blood vessels to destroy cancer cells from inside. This may be an option if your liver cancer has not spread beyond the liver and you can tolerate the procedure.
This trial tests combining radiation therapy (radioembolization) with surgery to remove part of the liver for people with a single large liver tumor (over 8 cm) that hasn't spread. The goal is to see if this approach can treat the tumor effectively.
This trial tests a treatment called Y-90 radioembolization (SIRT) for people with liver cancer that is too large to be removed surgically. The treatment delivers tiny radioactive beads directly to the tumor through the liver's blood supply, which may shrink the tumor and improve outcomes.
Hear when a new Liver Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.